|
Vision
To improve health outcomes for New Zealanders
through equitable access to quality medicines.
Our Mission
To advocate for patients' needs by influencing
public policy to achieve equitable access to quality medicines.
Core Values
| Ethical |
we take a responsible
approach and use evidence based arguments. |
| Accountable |
we are cognisant
of our responsibility to our members and to New Zealanders. |
| Collaborative |
we recognise the
fiscal pressures of providing health services and offer solutions
before criticism. |
| Pro-active |
we are forward
looking and want to drive positive change. |
| Commitment |
we are focused
on the challenges of achieving equity. |
Our work
A central objective of the RMI is to promote the benefits of a
strong research based medicines industry in New Zealand. Towards
this end it undertakes a number of key activities:
- Monitoring and evaluating health sector developments
- Undertaking research into issues of concern for the industry
- Making representations to central government on legislation
and policies affecting its members
- Maintaining relations with the Ministry of Health, its agencies
and other interest groups within the sector, such as the New Zealand
Medical Association.
For its member companies, the RMI provides a wide range of additional
services including:
- Briefings on policy initiatives and issues
- Information and advice to support member companies
- Public relations activity on behalf of the industry
Successful Self Regulation
The RMI's Code of Practice for advertising and promotion of pharmaceutical
products is proof that the industry can, and is, regulating itself.
Regular media audits show advertising by RMI members is generally
complying with the Code.
The Code is administered by a standing committee, comprising medical
and legal representatives, which has the power to direct the withdrawal
of advertising, public notification and to impose company fines.
|
